SUMOylation of DAXX with SUMO1

Stable Identifier
R-HSA-4085992
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

DAXX is SUMOylated at lysine-630 and lysine-631 with SUMO1 (Jang et al. 2002, Lalioti et al. 2002, Lin et al. 2006). SUMOylation of DAXX does not prevent it from localizing to PML oncogenic domains.

Literature References
PubMed ID Title Journal Year
12150977 Modification of Daxx by small ubiquitin-related modifier-1

Jang, MS, Ryu, SW, Kim, E

Biochem. Biophys. Res. Commun. 2002
11842083 The insulin-sensitive glucose transporter, GLUT4, interacts physically with Daxx. Two proteins with capacity to bind Ubc9 and conjugated to SUMO1

Lalioti, VS, Vergarajauregui, S, Pulido, D, Sandoval, IV

J. Biol. Chem. 2002
17081986 Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors

Lin, DY, Huang, YS, Jeng, JC, Kuo, HY, Chang, CC, Chao, TT, Ho, CC, Chen, YC, Lin, TP, Fang, HI, Hung, CC, Suen, CS, Hwang, MJ, Chang, KS, Maul, GG, Shih, HM

Mol. Cell 2006
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
SUMO transferase activity of SUMO1:C93-UBE2I [nucleoplasm]
Physical Entity
Activity
Orthologous Events
Authored
Reviewed
Created